Preventio of varicella zoster virus infection by immunization in aged patients with underlying diseases.

Preventio of varicella zoster virus infection by immunization in aged patients with underlying diseases. - Preventio of varicella zoster by immunization in aged underlying disease patients.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003639

Enrollment

Registered

2010-05-19

Start date

2010-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus

Interventions

From April 1 2010 to November 30 2010. Interventions:Immunization with 1 dose of live attenuated Varicella vaccine (BIKEN) to 10 aged individuals. From April 1 2010 to November 30 2010. Intervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: healthy aged individuals and diabetes mellitus patients controlled with HbA1c 7-9.5.

Exclusion criteria

Exclusion criteria: Patients with malignant diseases or autoimmune diseases. Patients with renal failure with sCr2. Smoker. Patients treated with steroid or aspirin.

Design outcomes

Primary

Measure	Time frame
immunogenecity	—

Secondary

Measure	Time frame
development of zoster	—

Countries

Japan

Contacts

Public ContactTaku Satomi

Kitano hospital, The Tazuke Kofukai Medical Research Institute Clinical Research

rinshou@kitano-hp.or.jp06-6312-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026